each of the directors of Nevro (D. Keith Grossman, Michael DeMane, Kirt Karros, Sri Kosaraju, Shawn T. McCormick, Kevin O’Boyle, Karen N. Prange, Susan Siegel, Kevin Thornal and Elizabeth Weatherman) resigned from the Board.
Departed
Shawn T. McCormick
Director
NEVRO CORP
Filed
April 3, 2025, 7:59 PM ET
each of the directors of Nevro (D. Keith Grossman, Michael DeMane, Kirt Karros, Sri Kosaraju, Shawn T. McCormick, Kevin O’Boyle, Karen N. Prange, Susan Siegel, Kevin Thornal and Elizabeth Weatherman) resigned from the Board.
Departed
Michael DeMane
Director
NEVRO CORP
Filed
April 3, 2025, 7:59 PM ET
each of the directors of Nevro (D. Keith Grossman, Michael DeMane, Kirt Karros, Sri Kosaraju, Shawn T. McCormick, Kevin O’Boyle, Karen N. Prange, Susan Siegel, Kevin Thornal and Elizabeth Weatherman) resigned from the Board.
Departed
Kirt Karros
Director
NEVRO CORP
Filed
April 3, 2025, 7:59 PM ET
each of the directors of Nevro (D. Keith Grossman, Michael DeMane, Kirt Karros, Sri Kosaraju, Shawn T. McCormick, Kevin O’Boyle, Karen N. Prange, Susan Siegel, Kevin Thornal and Elizabeth Weatherman) resigned from the Board.
Departed
D. Keith Grossman
Director
NEVRO CORP
Filed
April 3, 2025, 7:59 PM ET
each of the directors of Nevro (D. Keith Grossman, Michael DeMane, Kirt Karros, Sri Kosaraju, Shawn T. McCormick, Kevin O’Boyle, Karen N. Prange, Susan Siegel, Kevin Thornal and Elizabeth Weatherman) resigned from the Board.
Departed
Susan Siegel
Director
NEVRO CORP
Filed
April 3, 2025, 7:59 PM ET
each of the directors of Nevro (D. Keith Grossman, Michael DeMane, Kirt Karros, Sri Kosaraju, Shawn T. McCormick, Kevin O’Boyle, Karen N. Prange, Susan Siegel, Kevin Thornal and Elizabeth Weatherman) resigned from the Board.
Departed
Elizabeth Weatherman
Director
NEVRO CORP
Filed
April 3, 2025, 7:59 PM ET
each of the directors of Nevro (D. Keith Grossman, Michael DeMane, Kirt Karros, Sri Kosaraju, Shawn T. McCormick, Kevin O’Boyle, Karen N. Prange, Susan Siegel, Kevin Thornal and Elizabeth Weatherman) resigned from the Board.
Appointed
Keith Pfeil
Director
NEVRO CORP
Filed
April 3, 2025, 7:59 PM ET
each of Daniel Scavilla and Keith Pfeil, the directors of Merger Sub immediately prior to the Effective Time, became the directors of Nevro.
Appointed
Daniel Scavilla
Director
NEVRO CORP
Filed
April 3, 2025, 7:59 PM ET
each of Daniel Scavilla and Keith Pfeil, the directors of Merger Sub immediately prior to the Effective Time, became the directors of Nevro.
On March 31, 2025, the Board appointed Charles (“Chip”) Victor Bergh to the Board as a Class III director, effective as of April 1, 2025, with an initial term expiring at the Company’s 2025 annual meeting of stockholders.
On March 31, 2025, Beth Pritchard notified e.l.f. Beauty, Inc. (the “ Company ”) of her decision to resign from the Company’s Board of Directors (the “ Board ”) and all committees thereof, effective March 31, 2025.
Robert E. Grove has agreed to resign and has submitted his resignation to the Company’s Board and all committees thereof, effective as of April 2, 2025.
On March 31, 2025, the Board, on the recommendation of the Corporate Governance and Nominating Committee, appointed John A. Fichthorn as a director, effective April 3, 2025
On April 1, 2025, in connection with the IPO, Neil Leibman, Warren Thompson, and David Perlin (collectively with Steve Salis and Jamie Karson, the “Directors”) were appointed to the board of directors of the Company (the “Board”).
On April 1, 2025, in connection with the IPO, Neil Leibman, Warren Thompson, and David Perlin (collectively with Steve Salis and Jamie Karson, the “Directors”) were appointed to the board of directors of the Company (the “Board”).
On April 1, 2025, in connection with the IPO, Neil Leibman, Warren Thompson, and David Perlin (collectively with Steve Salis and Jamie Karson, the “Directors”) were appointed to the board of directors of the Company (the “Board”).
Departed
Roman Tkachenko
Director
4Front Ventures Corp.
Effective
2025-03-29
Filed
April 3, 2025, 7:59 PM ET
On March 29, 2025, Chetan Gulati, Leo Gontmakher, and Roman Tkachenko resigned from the Board of Directors of 4Front Ventures Corp.
Departed
Chetan Gulati
Director
4Front Ventures Corp.
Effective
2025-03-29
Filed
April 3, 2025, 7:59 PM ET
On March 29, 2025, Chetan Gulati, Leo Gontmakher, and Roman Tkachenko resigned from the Board of Directors of 4Front Ventures Corp.
Departed
Leo Gontmakher
Director
4Front Ventures Corp.
Effective
2025-03-29
Filed
April 3, 2025, 7:59 PM ET
On March 29, 2025, Chetan Gulati, Leo Gontmakher, and Roman Tkachenko resigned from the Board of Directors of 4Front Ventures Corp.
Effective April 3, 2025, the Board of Directors (the “Board”) of FutureFuel Corp. (the “Company”) increased the size of the Board to nine members and the Company appointed Pamela R. Butcher as a Class C member of the Board until her successor is duly elected and qualified or until her earlier death, resignation or removal.
On April 1, 2025, Robert Synowicki, Jr. confirmed to Knight-Swift Transportation Holdings Inc. (the "Company") that he will not be standing for reelection at the Company’s 2025 Annual Meeting of Stockholders.
Thomas J. DeRosa, a member of the board of directors (the “Board”), Chair of the Compensation Committee and a member of the Audit Committee of Empire State Realty Trust, Inc. (the “Company”), notified the Company of his intention to retire and not stand for re-election to the Board at the Company’s 2025 Annual Meeting of Shareholders, currently expected to be held on May 15, 2025 (the “Annual Meeting”).
Effective April 2, 2025, the Board of Directors (the “Board”) of Harmony Biosciences Holdings, Inc. (the “Company”) appointed Ron Philip, age 51, as a Class III director, filling the previously announced vacancy in the Board created by the resignation of Jack Bech Nielsen effective June 27, 2024.
each of Peter Nolan and General C. Robert Kehler notified the Company of their intent not to stand for re-election as a member of the Board at the 2025 Annual Meeting
each of Peter Nolan and General C. Robert Kehler notified the Company of their intent not to stand for re-election as a member of the Board at the 2025 Annual Meeting
appointed Carol DiBattiste, and Thomas D. Mitchell, to serve as independent members of the Board to fill the Board’s current vacancies, effective April 1, 2025
appointed Carol DiBattiste, and Thomas D. Mitchell, to serve as independent members of the Board to fill the Board’s current vacancies, effective April 1, 2025
Appointed
Jerry Jao
Member of the Board, Chairperson of the Audit Committee, Member of the Compensation Committee
On March 31, 2025, the board of directors (the “ Board ”) of FIGS, Inc. (the “ Company ”) appointed Jerry Jao to serve as a member of the Board, effective April 1, 2025 (the “ Effective Date ”).
On March 28, 2025, Alexander Baum notified the Board of Directors (the “Board”) of Insight Enterprises, Inc. (the “Company”) that he intends to retire from the Board and will not stand for election at the Company’s next annual meeting of stockholders (the “2025 Annual Meeting”).
it has increased the size of the Company’s Board of Directors (the "Board") to 11 members and has appointed Robert A. DeMichiei to fill the newly created seat on the Board, effective April 2, 2025.
On April 1, 2025, Aurora Cassirer submitted her resignation as a member of the board of directors of NanoVibronix, Inc. (the “Company”), which resignation became effective immediately.
Simultaneously, the Board of Directors of the Company appointed Mr. Thomas Fore to serve as a Director of the Company, effective March 20, 2025.
Departed
Judy Su
member of the Board of Directors
Virpax Pharmaceuticals, Inc.
Effective
2025-04-02
Filed
April 3, 2025, 7:59 PM ET
On April 2, 2025, Esha Randhawa, Charn Deol, and Judy Su each resigned from their positions as members of the Board of Directors of the Company, effective immediately.
Departed
Charn Deol
member of the Board of Directors
Virpax Pharmaceuticals, Inc.
Effective
2025-04-02
Filed
April 3, 2025, 7:59 PM ET
On April 2, 2025, Esha Randhawa, Charn Deol, and Judy Su each resigned from their positions as members of the Board of Directors of the Company, effective immediately.
Departed
Esha Randhawa
member of the Board of Directors
Virpax Pharmaceuticals, Inc.
Effective
2025-04-02
Filed
April 3, 2025, 7:59 PM ET
On April 2, 2025, Esha Randhawa, Charn Deol, and Judy Su each resigned from their positions as members of the Board of Directors of the Company, effective immediately.
Departed
Esha Randhawa
Member of the Board of Directors
Virpax Pharmaceuticals, Inc.
Effective
2025-04-02
Filed
April 3, 2025, 7:59 PM ET
On April 2, 2025, Esha Randhawa, Charn Deol, Judy Su, and Katharyn Field each resigned from their positions as members of the Board of Directors of the Company, effective immediately.
Departed
Judy Su
Member of the Board of Directors
Virpax Pharmaceuticals, Inc.
Effective
2025-04-02
Filed
April 3, 2025, 7:59 PM ET
On April 2, 2025, Esha Randhawa, Charn Deol, Judy Su, and Katharyn Field each resigned from their positions as members of the Board of Directors of the Company, effective immediately.
Departed
Charn Deol
Member of the Board of Directors
Virpax Pharmaceuticals, Inc.
Effective
2025-04-02
Filed
April 3, 2025, 7:59 PM ET
On April 2, 2025, Esha Randhawa, Charn Deol, Judy Su, and Katharyn Field each resigned from their positions as members of the Board of Directors of the Company, effective immediately.
Departed
Katharyn Field
Member of the Board of Directors
Virpax Pharmaceuticals, Inc.
Effective
2025-04-02
Filed
April 3, 2025, 7:59 PM ET
On April 2, 2025, Esha Randhawa, Charn Deol, Judy Su, and Katharyn Field each resigned from their positions as members of the Board of Directors of the Company, effective immediately.
On March 31, 2025, the Board of Directors Global-Smart.Tech Inc. (“the Board”), appointed Genismarlon Da Silva Nunes to serve as an Independent Director of the Global-Smart.Tech Inc. (“the Company”), effective immediately.
On April 1, 2025, Matthew Runkle was appointed to the Board of Directors (the “Board”) of Cheniere Energy, Inc. (the “Company”) pursuant to a right granted to CQP Holdco LP (f/k/a Blackstone CQP Holdco LP), a Delaware limited partnership, in an Investors’ and Registration Rights Agreement (the “Agreement”) dated as of July 31, 2012, among Cheniere Energy Partners, L.P., Cheniere Energy Partners GP, LLC, the Company, CQP Holdco LP and the other investor party thereto.
On March 31, 2025, the board of directors (the “Board”) of Starwood Real Estate Income Trust, Inc. (the “Company”) appointed Jonathan Pollack to serve as a member of the Board, effective April 1, 2025.
Appointed
Jennifer Chou
Director
ContextLogic Inc.
Effective
2025-03-31
Filed
April 2, 2025, 7:59 PM ET
On March 31, 2025, the board of directors (the “Board”) of ContextLogic Inc. (the “Company”) appointed Jennifer Chou to the Board, effective immediately.
On March 27, 2025, Heidi Kunz, a member of the Board of Directors (the “Board”) of Agilent Technologies, Inc. (the “Company”), a member of the Compensation Committee of the Board (the “Compensation Committee”), and a member of the Nominating/Corporate Governance Committee of the Board (together with the Compensation Committee, the “Committees”), notified the Chairman of the Board of her decision to resign from the Board and the Committees, effective as of May 21, 2025.
Departed
Dayna Grayson
Director
Desktop Metal, Inc.
Effective
2025-04-02
Filed
April 2, 2025, 7:59 PM ET
each of Ric Fulop, Scott Dussault, James Eisenstein, Dayna Grayson, Wen Hsieh, Jeff Immelt, Stephen Nigro, Steve Papa, Bilal Zuberi resigned and ceased to be directors of the Company and members of any committee or subcommittee of the Company’s Board of Directors as of the Effective Time.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.